12:00 AM
Jan 23, 2012
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Neurocrine completes follow-on

Neurocrine Biosciences Inc. (NASDAQ:NBIX), San Diego, Calif.
Business: Neurology, Cardiovascular, Genitourinary

Read the full 40 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >